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Aims: To quantify the risk of hospitalization for infections in Indigenous Australian adults with diabetes in
rural and remote communities.
Methods: 2787 Indigenous adults including 396 with diabetes at baseline from 19 communities in North
Queensland from 1998 to 2007 were included in the study. Main measures were weight, height, waist
circumference, blood pressure, fasting glucose, lipids, self-reported tobacco smoking, alcohol intake and
physical activity. Baseline data were linked to hospital separation data using probabilistic linkage. The
association between diabetes and hospitalization for all causes and infections was investigated using
generalized linear model (GLM) and adjusted for other baseline measurements.
Results: During a median follow up of 7 years, 461 participants were hospitalized with 762 episodes of
infection. 277 patients with diabetes (70%) were hospitalized at least once. 40% (110 in 277) were for
community acquired infections. Patients with diabetes were twice as likely to be hospitalized for infections as
those without diabetes (adjusted risk ratio 2.1, 95% CI 1.6–2.8), especially for urinary tract infections, cellulitis,
and septicaemia. Median length of stay was 6 (IQR 3–13) days for diabetes patients compared to 3.4 days (IQR
2–6.4) for those without diabetes (P b 0.001)
Conclusions: In addition to an already high rate of hospitalizations for infections among Indigenous compared
to non-Indigenous Australians, diabetes confers an additional risk for severe infections especially urinary tract
infection, cellulitis and septicaemia. Recovery is also comparatively slower. Early recognition and
management of these infections in the primary care setting may reduce this risk and better control of
glycaemia and its risk factors may improve underlying immune dysfunction.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Diabetes has become widely prevalent and is associated with
increased risk of cardio metabolic complications and infections
including increased infection-related mortality (Magliano et al.,
2015; Nwaneri, Cooper, & Bowen-Jones, 2013). Common excess
diabetes-related infections include respiratory tract infections, pyelo-
nephritis and cystitis, urinary tract infections, soft-tissue infections,
ear infections and cholecystitis (Joshi, Caputo, Weitekamp, &
Karchmer, 1999; Nitzan, Elias, Chazan, & Saliba, 2015). This doubling
of infection risk appears to be consistent across different studies and
also reﬂects the pattern of community-acquired infection in the
general population (Casqueiro, Casqueiro, & Alves, 2012; Klekotaka,
Mizgala, & Krol, 2015). The raised risk among people with diabetes
suggests a general underlying impairment in immune function whichs no conﬂict of interest.
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Inc. This is an open access article uincludes lowered interleukin production in response to speciﬁc
infections, neutrophil dysfunction, the direct effect of glycaemia
which may increase virulence of some pathogens, and the combined
effect of glycosuria and urinary tract dysmotility (Peleg, Weerarathna,
McCarthy, & Davis, 2007).
Indigenous Australians have extremely high prevalence of type 2
diabetes with higher proportions in remote Indigenous communities
where up to 50% of adults are affected (Australian Indigenous
Australian Indigenous HealthInfoNet, 2015). Likewise, the incidence
of diabetes is around 8 times higher than the non-Indigenous
population (McDermott, Li, & Campbell, 2010). Indigenous Austra-
lians are hospitalized at nearly 4 times the rate for the general
population for all causes (Australian Institute of Health & Welfare,
2011). The risk of infections in Indigenous Australians with diabetes
has been reported ﬁrst time in Central Australia of a double the risk
compared to matched Aboriginal controls (Patel, Phillips, & Cabaron,
1991). The other urban Western Australian study in a sample of 120
adults found a similarwithin-Aboriginal comparison risk (Hamilton et al.,
2013). Reports from Canada, the Netherlands and non-Aboriginal
Australia suggest increased susceptibility to pneumonia, urinary tractnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
International Classiﬁcation of Disease (ICD)-9-CM and ICD-10-AM codes for selected
infections in the present study.
Infection ICD-9-CM ICD-10-AM
Respiratory/ENT 380, 382, 461–463, 465, 466,
472, 480–488, 490–493, 519
A161, A169, J10–J18, J20–J21,
J00–06, J31–J32, J40,
J45, H66–H67, J85
Digestive 001–009, 70 A00–A09, B15–B19, K35,
K37, K80–K81
Urinary 540, 575, 590, 595,
599, 601, 090–099
N10–13, N30, N39, N41,
R30, R33. A50–A54, A70–A74
Cellulitis 680–686, 785, 917 L00–L04, L08, L88–L98, R02
Septicaemia 036, 038, 041, 790, 995 A39–41, A49
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2005; Shah & Hux, 2003).
Here we quantify the 7 year risk of hospitalization for infectious
diseases including respiratory/ear, nose, and throat (ENT), urinary,
digestive, cellulitis, septicaemia, and the length of hospital stay (LOS)
in a large cohort of Aboriginal and Torres Strait Islander adults with
and without diabetes from rural and remote communities in North
Queensland between 1998 and 2007.
2. Methods
2.1. Study population
Baseline data were collected from 2787 adults in 19 rural
Indigenous communities across three health districts in far north
Queensland. The cohort participated in the “Well Person's Health
Check” (WPHC) between 1998 and 2000. Methods for this cross
sectional study have been reported in detail elsewhere (Miller et al.,
2002). Brieﬂy, all Indigenous residents of the communities were
invited to attend a health check. The study achieved a participation
rate of 44.5% with greater participation noted in smaller communities
based on the local census data. The study protocols were approved by
the Cairns Base Hospital Human Research Ethics Committee with
support from the peak Indigenous Health Organizations, Apunipima
Cape York Health Council and the Torres Strait and Northern
Peninsula Area Health Council.
2.2. Measurements
Weight was recorded with light clothing to the nearest 0.1 Kg, and
height and waist circumference (WC) were recorded to the nearest
centimetre by technicians. Physical activity was self-reported using a
7-day recall method and was deﬁned using theWHO criteria in which
‘enough’means doing moderate to vigorous physical activity for more
than 30 min/d for 5 days in the week before the survey. Daily
consumption of tobacco and alcohol were self-reported. Blood
pressure (BP) was the average of three measurements using a
Dinamap model 800 automated blood pressure monitor (Critikon;
Tampa FL, US). Baseline hypertension was ascertained either by
detection of high BP at examination (measured BP N140/90 mmHg)
or previous conﬁrmed diagnosis or currently prescribed antihyper-
tensive medication (by medical record review).
Total cholesterol, high density lipoprotein cholesterol (HDLC),
triglycerides, and glucose were measured on fasting blood using
photometric enzyme endpoint assay with Cobas Integra 700/400
(Roche Diagnostic, USA). Diabetes was deﬁned as either clinical
diagnosis veriﬁed by the participants' medical records or a 2 hour
glucose tolerance test, or fasting blood glucose level N7.0 mmol/L.
2.3. Hospitalization for infections
Hospitalization for consenting WPHC participants during
1998–2007 was identiﬁed via a manual search (by a registered
nurse with experience working in the region) of the Queensland
Health hospital record systems. Hospitalization data were merged
with baseline survey data by probabilistic linkage using a mapping
table, which linked WPHC reference number, hospital facility code
and local unit record number.
Hospitalized infections were grouped into the following: respira-
tory/ENT, digestive, urinary, cellulitis, and septicaemia. Respiratory/
ENT infections included bronchitis, pneumonia and others, and ENT
infections; digestive infections included gastroenteritis, hepatitis,
cholecystitis, and appendicitis; urinary infections included pyelone-
phritis and other urinary tract infections, pelvic inﬂammatory
diseases. All hospital admissions with the International Classiﬁcation
of Disease (ICD)-9-CM and ICD-10-AM codes for the selectedinfections as principal diagnosis were identiﬁed. Table 1 listed the
ICD codes for the selected infections from hospitalization separation
during 1998–2007. The LOS of each corresponding admission was
recorded and the mean LOS was summarized within each infection
groups. Incidence was deﬁned as any hospitalized infections after the
enrolment date.2.4. Statistical analysis
Baseline characteristics including age, sex, and ethnicity,
self-reported behaviours including smoking, and drinking, blood
pressure, diabetes/fasting glucose, blood lipids, were compared
between hospitalizations and by infections and tested using t test or
chi-square test orMann–Whitney U-test or Fisher's exact test. The risk
of hospitalized infections with baseline diabetes or glucose tertiles
was investigated using generalized linear model (GLM). The outcome
was hospitalized infections, and the study factor was baseline
diabetes/glucose tertiles. The family in the models was “binomial”
and the link was “log”. The association was further adjusted for age,
sex, body mass index (BMI), other biomedical factors (blood pressure,
lipid), and lifestyle factors (smoking, drinking, physical activity). LOS
in days by baseline diabetes was compared and tested using Mann–
Whitney U test. The association with diabetes was assessed using log
transformed LOS as outcome in GLM with family “gauss” and link
“identity” and adjusted for the above factors. The analysis was carried
out using STATA 13 (STATACorp, College Station, TX, USA) and
signiﬁcance level was set at two-sided P b 0.05.3. Results
3.1. Characteristics of the study cohort and hospitalization for infections
Among the 2787 Indigenous participants included in this study,
1448 were males (52.0%) with an overall mean age of 37.1 (SD
15.3 years). 1641 were Aboriginal people. At baseline, 61% were
overweight and/obese deﬁned as BMI ≥25 kg/m2, 58% self-reported as
smokers and 69% as alcohol drinkers, less than a quarter (24%) of
people met the PA recommendations. 396 people (14%) had diabetes
and 790 (28%) had hypertension. A total of 1753 were hospitalized
during 1998–2007. 277 diabetes patients in the 396 participants
(70%) were admitted at least once during the study period. Baseline
characteristics were not signiﬁcantly different by hospitalization
(Appendix Table A1).
During the follow up, a total of 762 episodes of infections were
identiﬁed in 461 participants from the cohort. 182 participants were
hospitalized with infections of respiratory system and ENT, 73 with
infections of the digestive system, 107 had infections of the urinary
system, 168 with cellulitis, and 34 with septicaemia (Table 2). 110
inpatients were with infections in the 227 diabetes patients (40%).
Table 2
New hospitalization for selected infections from 1998 to 2007 for the whole WPHC
cohort.
Infections No Episodes LOS median (IQR)
Respiratory/ENT Pneumonia and others 132 176 4 (2–7)
Bronchitis 37 68 3 (1–5)
ENT infection 31 33 2 (1–4)
Digestive Gastroenteritis 4 4 2 (1.5–2)
Hepatitis 1 1 5
Cholecystitis 42 48 2.5 (1–4.5)
Appendicitis 28 30 3.5 (2–6)
Urinary PID 36 43 3 (1–6)
Pyelonephritis and UTI 72 102 2 (4–3)
Cellulitis Cellulitis 168 216 4 (2–7)
Septicaemia Septicaemia 34 41 8 (5–13)
Table 4
Number (%) of people hospitalized with selected infections by baseline diabetes.
No diabetes n = 2391 Diabetes Yes n = 396 p
Respiratory/ENT 145 (6.1) 37 (9.3) 0.014
Digestive 63 (2.6) 10 (2.5) 0.899
Urinary 74 (3.1) 33 (8.3) b0.001
Cellulitis 111 (4.6) 57 (14.4) b0.001
Septicaemia 17 (0.7) 17 (4.3) b0.001
Overall 348 (14.5) 113 (28.5) b0.001
P from chi-square test.
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for infections
Table 3 summarizes the baseline characteristics of the patients
hospitalized with infections. Hospitalization with respiratory/ENT
infections was more likely among older participants or with lower
BMI and higher BP. Hospital admission for gastro-intestinal infections
was more likely among females and those with lower SBP and
smokers, but was not different by age, ethnicity, and BMI, lipids and
drinking proﬁle. Hospitalization with infections of the urinary system
was more likely for females, those with lower cholesterol and HDLC,
and smokers, but did not differ by age, ethnicity, BMI and drinking
status. Admission with cellulitis was more likely among older
participants, or with higher BMI or SBP. Hospitalization with
septicaemia was more likely among older participants, with higher
BMI or BP, or non-smokers.
The proportion of patients with severe infection was signiﬁcantly
higher in those with diabetes at baseline (396 patients) except for
infections of the digestive system. For example, 9.3% participants with
diabetes were hospitalized with respiratory/ENT infections compared
to 6.5% without diabetes during the follow up period (P b 0.014)
(Table 4).
Among the 396 participants with diabetes at baseline, 383 had a
fasting glucose in the 3rd tertile (≥5.3 mmol/L). 7 were in the other
tertiles and 6 patients did not have baseline glucose recorded. Among
those free of diabetes at baseline, increased glucose was not
associated with infection hospitalization. The proportion of total
infections was higher in those with glucose ≥5.3 (20.7% for the 3rdTable 3
Characteristics of hospitalized participants by selected infections in North Queensland.
Respiratory/ENT
N = 182
Digestive
N = 73
Urinary
N = 107
Cellulitis
N = 168
Septicaemia
N = 34
Age (years) ⁎R D C S 45.5 (18.4) 34.0 (13.0) 38.0 (17.4) 40.4 (15.5) 48.8 (15.9)
Male % ⁎D U 95 (52.2) 23 (31.5) 90 (84.1) 84 (50.0) 17 (50.0)
Aboriginal % 121 (66.5) 40 (54.8) 69 (64.5) 91 (54.2) 17 (50.0)
WC (cm) ⁎C 95.3 (17.2) 96.1 (16.6) 95.8 (17.5) 100.0 (18.6) 106.8 (16.5)
BMI (kg/m2) ⁎R C S 26.7 (7.1) 27.7 (7.0) 27.4 (7.4) 29.1 (8.0) 31.3 (8.2)
SBP (mmHg) ⁎R D C S 134.3 (24.4) 124.5 (19.8) 127.7 (20.1) 132.6 (21.0) 149.4 (24.1)
DBP (mmHg) ⁎R S 73.9 (14.9) 68.8 (12.9) 69.7 (12.2) 72.1 (13.4) 77.7 (14.5)
Cholesterol (mmol/L) ⁎U 4.9 (1.1) 4.8 (1.0) 4.7 (1.1) 4.9 (1.1) 5.1 (1.1)
HDLC (mmol/L)⁎D U 1.2 (0.4) 1.1 (0.2) 1.1 (0.3) 1.1 (0.3) 1.0 (0.3)
Median Triglycerides (mmol/L) ⁎D 1.8 (1.8) 1.3 (1.5) 1.5 (1.2) 2.1 (1.9) 2.5 (1.8)
BMI ≥25% 103 (56.6) 45 (61.6) 60 (56.1) 102 (60.7) 26 (76.5)
Hypertension% ⁎R C 71 (39.0) 17 (23.3) 25 (23.4) 59 (35.1) 22 (64.7)
Smokers % ⁎D U S 119 (69.6) 56 (76.7) 71 (67.0) 86 (52.4) 12 (35.3)
Alcohol drinkers % 110 (62.9) 55 (76.4) 65 (61.9) 116 (69.9) 18 (56.3)
PA enough % 39 (21.4) 59 (80.8) 90 (84.1) 36 (21.4) 6 (17.7)
Number in the table showing mean (SD) or n (%);
*P b 0.05 from t test or chi-square test or the corresponding non-parametric tests of Mann–Whitney test or Fisher's exact test; R D C S indicating signiﬁcant difference by categories o
“Respiratory/ENT” “Digestive” “Urinary” “Cellulitis” “Septicaemia”glucose tertile vs 15% for the 1st tertile, P b 0.001), particularly for
cellulitis and septicaemia (Appendix Table A2).
3.3. The association between diabetes/glucose and hospitalization for
infections
Regression models showed that participants with diabetes at
baseline were twice as likely to be hospitalized for any infection as
those without diabetes (adjusted risk ratio 2.1, 95% CI: 1.6–2.8).
Speciﬁcally, compared to those free of diabetes, urinary infection
conferred the greatest excess risk (adjusted RR 3.6, 95% CI: 2.2–5.7),
followed by septicaemia and cellulitis (adjusted RR = 3.3 (95% CI
1.6–6.8 and 2.9, 95% CI: 2.0–4.1), respectively. Baseline fasting glucose
≥5.3 mmol/L conferred a crude overall excess risk of infection of 1.4
but this reduced after adjustment. However for urinary infections, the
risk excess remained after adjustment, suggesting that glycaemia
itself may play a role in these speciﬁc infections (Table 5).
Median LOS for all infections was greater in older and Aboriginal
participants but not related to BMI, blood pressure, blood lipids or
lifestyle factors. The LOS for infections of respiratory/ENT, digestive,
urinary systems as well as cellulitis varied from 4 to 5 days and was
longer in diabetes patients than those without (LOS varied from 2.5 to
3.5 days) (Table 6). Log transformed total LOS for all infections in
diabetes patients was 1.6 times (95% CI 1.3–2.0) greater than those
without diabetes after adjustment, and log LOS for urinary infections
was doubled in diabetes (95% CI 1.2–3.3).
4. Discussion
An extremely high background rate of community-acquired
infection plus high prevalence of type 2 diabetes among Indigenous
Australians leads to excess hospitalization for infections. We found onf
Table 5
7-year follow up risk of hospitalized infections associated with diabetes/glucose (odds
ratio and 95% CI).
RR Diabetes Glucose
4.7–5.2
Glucose
≥5.3 mmol/L
Respiratory/ENT Crude 1.5 (1.1–2.2) 0.9 (0.7–1.4) 1.3 (1.0–1.9)
Adjusted 1.2 (0.8–1.7) 0.8 (0.6–1.2) 1.0 (0.7–1.5)
Digestive Crude 1.0 (0.5–1.9) 0.7 (0.4–1.2) 0.6 (0.4–1.1)
Adjusted 1.1 (0.5–2.2) 0.8 (0.4–1.4) 0.8 (0.4–1.4)
Urinary Crude 2.7 (1.8–4.0) 1.1 (0.7–1.8) 1.6 (1.1–2.4)
Adjusted 3.6 (2.2–5.7) 1.3 (0.8–2.1) 2.1 (1.3–3.5)
Cellulitis Crude 3.1 (2.3–4.2) 0.7 (0.4–1.0) 1.7 (1.2–2.3)
Adjusted 2.9 (2.0–4.1) 0.6 (0.4–1.0) 1.4 (1.0–2.1)
Septicaemia Crude 6.0 (3.1–11.7) 1.0 (0.4–3.1) 3.3 (1.4–7.7)
Adjusted 3.3 (1.6–6.8) 0.7 (0.2–2.1) 1.2 (0.5–3.1)
Overall Crude 2.4 (1.8–3.0) 0.9 (0.7–1.1) 1.4 (1.1–1.8)
Adjusted 2.1 (1.6–2.8) 0.8 (0.6–1.1) 1.2 (0.9–1.6)
Risk ratios from GLM with family as binomial and link as log;
The reference for the models by diabetes being “no” and by glucose being lst tertile of
b4.7 mmol/L.
The adjusted RRs from models included age, gender, ethnicity, baseline BMI,
hypertension, lipid, smoking and drinking
Table A1
Characteristics of Indigenous participants in North Queensland during 1998–2007.
Not hospitalized
N = 1034
Hospitalized
N = 1753
Total
N = 2787
Mean (SD) or
n (%)
Mean (SD) or
n (%)
Mean (SD) or
n (%)
Age (years) 36.0 (14.2) 37.7 (15.9) 37.1 (15.3)
Male % 460 (44.5) 988 (56.4) 1448 (52.0)
Aboriginal % 604 (58.4) 1037 (59.2) 1641 (58.9)
WC (cm) 95.0 (16.6) 95.6 (16.9) 95.4 (16.8)
BMI (kg/m2) 27.8 (7.0) 27.6 (7.2) 27.7 (7.1)
SBP (mmHg) 129.4 (17.0) 129.9 (20.6) 129.7 (19.3)
DBP (mmHg) 71.3 (12.8) 71.1 (13.9) 71.2 (13.5)
Fasting glucose (mmol/L) 5.5 (2.2) 5.8 (2.8) 5.7 (2.6)
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northern Australian communities were hospitalized each year for
severe infection over a seven year period, and was approximately
double that of the non-diabetic cohort. This rate is 10 times higher
than an urban non-Indigenous Australian cohort (Hamilton et al.,
2013) which found 20% of those with diabetes were hospitalized with
infection over a 12 year period (1.67% per year on average). Further,
we found that length of hospital stay was nearly double for patients
with diabetes, suggesting more severe disease or reduced respon-
siveness to treatment or both. A large Canadian study in patients with
unspeciﬁed diabetes compared to matched controls sourced from
administrative data found a similar doubling of risk for
infection-related hospitalization and deaths from infections (Shah &
Hux, 2003).
We found the most frequently hospitalized infections were
cellulitis followed by urinary, digestive infectionsmainly cholecystitis,
and lastly septicaemia. Skin and soft tissue infection is highly
prevalent among Australian Indigenous children especially in remote
areas (Clucas et al., 2008). Socioeconomic status and poor housing
contribute to the spread of these infections (Bailie et al., 2005). The
most frequent pathogens causing skin infection in children were
group A streptococcus and Staphylococcus aureus (Valery et al., 2008)
so it is therefore not surprising that cellulitis was common in adults.
Severe urinary tract infection was also highly prevalent in this
cohort and having diabetes ampliﬁed this risk 3-fold. This is a similar
pattern to that from studies in US (Fu et al., 2014) and UK (Hirji, Guo,
Andersson, Hammar, & Gomez-Caminero, 2012) reporting a relative
risk of two among adults with diabetes for UTI compared to matchedTable 6
Total LOS (days) of hospitalization of infections by diabetes status.
No diabetes n = 2391 Diabetes Yes n = 396 p
No. Median (IQR) No Median (IQR)
Respiratory/ENT 145 3 (2–6) 37 4 (3–7) 0.02
Digestive 63 3 (1–4) 10 5 (3–14) 0.04
Urinary 74 2.5 (2–4) 33 4 (2–6) 0.04
Cellulitis 111 3.5 (2–6) 57 5 (3–11) 0.001
Septicaemia 17 7 (5.5–18) 17 8 (6–12.5) 0.836
Overall 348 3.4 (2–6.4) 113 6 (4–13) b0.001
P from Mann–Whitney U testcontrols. Direct comparisons with our cohort are not possible as the
Canadian and UK studies used population-based registration data.
Strengths of this study include a broadly representative
community-based sample of both Aboriginal and Torres Strait
Islander adults from remote sites, objective baseline clinical mea-
surements and a cohort design. Limitations include a relatively short
follow up period, lack of detailed medical and family history and
potential unmeasured confounding factors. Hospitalization data for
people moving away from the study area were not always accessible
and the hospital admission data were potentially prone to coding
errors.
In summary, we found an extremely high absolute risk for
serious community-acquired infection in this Indigenous cohort
from north Queensland remote communities, and that having
diabetes doubled this risk and resulted in more severe illness and
longer hospital stays. Improving community housing conditions
and opportunities to control spread of infection more generally
would reduce the high background rates of severe infection. The
high prevalence of diabetes in these communities, where up to
half of all adults are affected, means that there will also be high
absolute numbers of infections with increased severity. Pro-active
and aggressive management of early infection, especially cellulitis,
in people with diabetes through the primary care service can
reduce complications, including hospitalization for infections
(McDermott & Segal, 2006).
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Appendix ACholesterol (mmol/L) 5.0 (1.0) 4.9 (1.1) 4.9 (1.1)
HDLC (mmol/L) 1.1 (0.3) 1.2 (0.3) 1.2 (0.3)
Med ian t r i g l y ce r ide s
(mmol/L)
1.3 (0.9–2.0) 1.4 (0.9–2.1) 1.4 (0.9–2.1)
BMI ≥25% 641 (62.0) 1061 (60.5) 1702 (61.1)
Hypertension % 282 (27.3) 508 (29.0) 790 (28.4)
Diabetes % 119 (11.5) 277 (15.8) 396 (14.2)
Smokers % 569 (55.4) 1027 (59.0) 1596 (57.7)
Alcohol drinkers % 702 (70.8) 1167 (68.5) 1869 (69.3)
PA enough % 269 (26.0) 386 (22.0) 655 (23.5)
Hypertension was ascertained either by detection of high BP at examination (measured
BP N140/90 mmHg) or previous conﬁrmed diagnosis or currently prescribed
antihypertensive medication;
Diabetes was deﬁned as either clinical diagnosis veriﬁed by the participants' medical
records or a 2 hour glucose tolerance test or fasting blood glucose level N7.0 mmol/L.
Physical activity was deﬁned using the WHO criteria in which ‘enough’ means doing
moderate to vigorous physical activity for more than 30 min/d for 5 days.
Table A2
Number (%) of people hospitalized with selected infections by glucose tertiles.
1st tertile (b4.7)
n = 990
2nd tertile
n = 814
3rd tertile (≥5.3)
n = 898
p
Respiratory/ENT 59 (6.0) 46 (5.6) 72 (8.0) 0.091
Digestive 33 (3.3) 19 (2.3) 19 (2.1) 0.210
Urinary 31 (3.1) 28 (3.4) 44 (4.9) 0.108
Cellulitis 53 (5.3) 29 (3.6) 82 (9.1) b0.001
Septicaemia 7 (0.7) 6 (0.7) 21 (2.3) 0.002
Overall 152 (15.4) 109 (13.4) 186 (20.7) b0.001
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